CME/CE Information

Target Audience

This activity was developed for physicians, nurses, and other healthcare professionals with an interest in MS.

Goal

Statement of Need
Multiple sclerosis (MS) is a heterogeneous disease with a highly variable clinical course and response to therapy. Early treatment with disease-modifying therapy can avoid axonal damage, reduce relapse rates, and delay progression, but the long-term management of MS remains challenging. Additionally, limitations in the effectiveness, tolerability, adherence, and toxicity of currently approved MS treatments underscore the need for new therapies. Advances in understanding of MS pathogenesis have elucidated targets for novel MS therapies that might expand treatment options. While translational and clinical research has revealed many new opportunities, healthcare providers striving to transform state-of-the-art research into improved care for MS patients will need to navigate an increasingly complex treatment landscape. This program is intended to help clinicians caring for MS patients gain a clearer understanding of the evolving picture of immunopathogenesis of MS and how this knowledge has provided the rationale for new mechanisms of action of novel therapies.

This knowledge will provide the groundwork for presentations on the rationale and clinical trial results with emerging agents. An expert panel will then discuss the potential role of new agents in the optimization of MS management, including their use in addressing the unmet needs of patient populations, adherence, combination and sequencing of therapies, risk-benefit assessment, and quality of life.

Learning Objectives

Upon completion of this activity, participants should be able to:

1. Discuss the rationale and mechanisms of action of novel treatment options for MS;
2. Review the relation of new therapy options to the role of B and T cells in MS pathogenesis;
3. Describe the potential clinical place of novel therapies in MS treatment and approaches to patient selection;
4. Summarize the benefits of combined, sequential, and multitargeted therapies for MS.

Accreditation Statements

For Physicians

This program is sponsored by MEC. This activity was developed in collaboration with Medical Education Collaborative and the Discovery Institute of Medical Education, New York Office

Medical Education Collaborative, Inc. (MEC) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

MEC designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303)420-3252 or email inquire@meccme.org.

For Nurses

 ANCC
Medical Education Collaborative (MEC) is the accredited provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

RNs, LPNs, LVNs and NPs can receive up to 1.7 contact hours for participation in this program. This program is cosponsored with Medical Education Collaborative, Inc. (MEC) and Discovery Institute of Medical Education (DIME). Provider approved by the California Board of Registered Nursing, Provider Number CEP 12990, for 2.0 contact hour(s).

For questions concerning credit in the state of California please contact MEC online at www.meccme.org or by phone at 303-420-3252.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

1. Read the target audience, learning objectives, and author disclosures.
2. Study the educational content online or printed out.
3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

Hardware/Software Requirements

Medscape requires version 4.x browsers or higher from Microsoft or Netscape. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.